4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Emilia-Romagna Surgical Colorectal Cancer Audit- ESCA (ESCA)

Emilia-Romagna Surgical Colorectal Cancer Audit- ESCA (ESCA)

Study Description
Brief Summary:
Focus of this project is to evaluate the possible financial benefit resulting from an optimization of surgical outcomes throughout a collaborative and systematic auditing activity.The primary objective of this analysis is to assess the employed resources by National Health System related to surgical activities for primary colorectal cancer during a collaborative and systematic auditing activity in 8 Surgical Units of Emilia-Romagna

Condition or disease Intervention/treatment
Financial Benefit Colorectal Cancer Surgery Auditing Activity Procedure: all colorectal cancer surgical procedures

Detailed Description:

Focus of this project is to evaluate the possible financial benefit resulting from an optimization of surgical outcomes throughout a collaborative and systematic auditing activity.

The primary objective of this analysis is to assess the employed resources by National Health System related to surgical activities for primary colorectal cancer during a collaborative and systematic auditing activity in 8 Surgical Units of Emilia-Romagna. A project team composed by experts in colorectal cancer care will be created with the task of identifying the needed resources to allocate to the project and the set of administrative, economic and performance indicators to be measured during the project. A friendly, time-preserving dataset that includes all the items to be collected to measure established indicators will be developed. An analysis on costs and performance indicators will be conducted on colorectal procedures performed between 1 January 2019 and 31 December 2019 within the participating centers. From the second year auditing activity will be implemented among institutions of Emilia-Romagna. Analysis results obtained from the first year of collecting data will be used as a starting feedback report to implement the auditing activity dedicated to colorectal cancer. During the whole second year monthly feedback reports will be drafted and used for monitoring costs and performances outcomes of colorectal surgery procedures between 1 January 2020 and 31 December 2020.

At the end of the second year a final analysis will be performed to compare resources employed for colorectal cancer surgery between the first and second year. Economical and performance data will be collected.

Focusing on costs, the main sources to be used are administrative databases. Full in-hospital costs will be collected for each patient for the time interval between the day of admission for surgery and the following post-operative 90-days. The Diagnosis Related Groups (DRG) standardized payments will be used to calculate inpatient costs.

Another source for cost and performance information is the clinical chart (paper or electronic) in all its parts. The investigators will focus primarily on set of data, that potentially could contribute to define the cost of care on basis of post-operative pathway. Key performance indicators common to both colon and rectal surgery or specific for one of the two surgical procedure will be considered.

Study Design
Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 1400 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 6 Months
Official Title: A Plan for Evaluating Costs and Outcomes of Colorectal Surgery in Emilia-Romagna (Emilia-Romagna Surgical Colorectal Cancer Audit-ESCA)
Actual Study Start Date : April 16, 2019
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : December 31, 2020
Arms and Interventions
Group/Cohort Intervention/treatment
Colon surgery
patients diagnosed with colon cancer, who undergone at least one surgical procedure at one of participating hospitals during the observational period
Procedure: all colorectal cancer surgical procedures
colorectal cancer surgical procedures

Rectal surgery
patients diagnosed with rectal cancer, who undergone at least one surgical procedure at one of participating hospitals during the observational period
Procedure: all colorectal cancer surgical procedures
colorectal cancer surgical procedures

Outcome Measures
Primary Outcome Measures :
  1. health care resources utilization (HCRU) [ Time Frame: 90 day post surgery ]
    To identify the resources delivered to surgical patients. Resource are retrieved from administrative database.

  2. Cost relate to HCRU [ Time Frame: 90 day post-surgery ]
    To identify the significant cost drivers for the surgical management of colorectal cancer patients and to verify the impact on economic resource consumption of the systematic auditing activities. Costs are retrieved from adminatrative database.


Secondary Outcome Measures :
  1. % of patients with post-operative complications [ Time Frame: 180 days post surgery ]
    To assess the frequency of post-operative complications, unplanned re-interventions and re-admission. This outcome is measured from data collected in Case Report Form (CRF)

  2. Rate of mortality at 30 days [ Time Frame: 30 days post surgery ]
    To assess mortality rates at 30 days. This outcome is measured from data collected in CRF and from administrative database.

  3. Rate of mortality at 90 days [ Time Frame: 90 days post surgery ]
    To assess mortality rates at 90 days. This outcome is measured from data collected in CRF and from administrative database.

  4. Rate of mortality at 180 days [ Time Frame: 180 days post surgery ]
    To assess mortality rates at 180 days. This outcome is measured from data collected in CRF and from administrative database.

  5. % of patients discussed in Multidisciplinary team meeting [ Time Frame: 180 days post surgery ]
    To assess the number of patient discussed within a multidisciplinary team meeting before colon rectal surgery. This outcome is measured from data collected in CRF.

  6. % of patients who underwent minimally invasive resection [ Time Frame: 180 day post surgery ]
    To assess the number of minimally invasive resections. This outcome is measured from data collected in CRF.

  7. Conversion rate [ Time Frame: 180 day post surgery ]
    to assess the rate of conversion surgery. This outcome is measured from data collected in CRF.

  8. % of patients with adequacy of lymph node sampling [ Time Frame: 180 days post surgery ]
    To assess adequate intraoperative lymph node sampling of colorectal surgery. This outcome will be measured from data collected in CRF.

  9. Rate of anastomosis [ Time Frame: 180 days post surgery ]
    To assess the rate of anastomosis after low anterior resection vs terminal colostomy. This outcome will be measured from relative data collected in CRF.

  10. Rate of Miles procedure [ Time Frame: 180 days post surgery ]
    to assess the rate of Miles procedures in rectal cancer patients. This outcome is measured from data collected in CRF.

  11. Quality of Total Mesorectal Excision: rate of positive Circumferential Resection Margin in patients with rectal cancer. [ Time Frame: 180 days post surgery ]
    To assess the rate of positive Circumferential Resection Margin in rectal cancer patient. This outcome will be measured from data collected in CRF.

  12. Rate of loop ileostomy in patients with rectal cancer [ Time Frame: 180 days post surgery ]
    To assess the rate of loop ileostomy after rectal cancer resection. This outcome is measured from data collected in CRF.

  13. % of patients with rectal cancer who underwent preoperative chemo-radiation therapy [ Time Frame: 180 days post surgery ]
    To assess the appropriateness of preoperative chemo-radiation therapy in rectal cancer patients. This outcome is measured from data collected in CRF.

  14. Rate of preoperative chemo-radiation therapy in patients with rectal cancer [ Time Frame: 180 days post surgery ]
    To assess the rate of preoperative chemo-radiation therapy in rectal cancer patients. This outcome is measured from data collected in CRF.


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All consecutive patients diagnosed with malignant colorectal cancer, who undergone at least one surgical procedure at one of participating hospitals during the observational period will be collected
Criteria

Inclusion Criteria:

  • Histological diagnosis of malignant colorectal cancer;
  • Underwent colorectal cancer surgery;

Exclusion Criteria:

• multiple synchronous primary tumours;

Contacts and Locations

Contacts
Layout table for location contacts
Contact: Valentina Danesi, engineer 00390543739264 valentina.danesi@irst.emr.it

Locations
Layout table for location information
Italy
Istituto Scientifico Romagnolo per lo studio e la cura dei tumori Recruiting
Meldola, FC, Italy, 47014
Contact: Valentina Danesi, Biomedical Engineering    00390543739264    valentina.danesi@irst.emr.it   
Principal Investigator: Mattia Altini, physician         
AUO Chirurgia Generale e D'Urgenza Ospedale M.Bufalini Recruiting
Cesena, Forli-Cesena, Italy, 47521
Contact: Luca Ansaloni, physician       luca.ansaloni@auslromagna.it   
Principal Investigator: Luca Ansaloni, physician         
AUO CHIRURGIA GENERALE OSPEDALE G. B. Morgagni- Pierantoni Recruiting
Forlì, Forli-Cesena, Italy, 47121
Contact: Giorgio Ercolani, physician       giorgio.ercolani2@unibo.it   
Principal Investigator: Giorgio Ercolani, physician         
Auo Chirurgia Generale Ospedale Degli Infermi Recruiting
Faenza, Ravenna, Italy, 48018
Contact: Giampaolo Ugolini, physician       giampaolo.ugolini@auslromagna.it   
Principal Investigator: Giampaolo Ugolini, physician         
AUO Chirurgia Generale Ospedale Umberto I Recruiting
Lugo, Ravenna, Italy
Contact: Rosario Mario Tranchino, physician       rosariomario.tranchino@auslromagna.it   
Principal Investigator: Rosario Mario Tranchino, physician         
AUO Chirurgia Generale Ospedale Ceccarini Recruiting
Riccione, Rimini, Italy, 47838
Contact: Andrea Lucchi, physician       andrea.lucchi@auslromagna.it   
Principal Investigator: Andrea Lucchi, physician         
AOU Chirurgia Generale Ospedale G. Da Saliceto Not yet recruiting
Piacenza, Italy, 29121
Contact: Patrizio Capelli, physician       p.capelli@ausl.pc.it   
Principal Investigator: Patrizio Capelli, physician         
AUO Chirurgia Generale ed Urgenza Ospedale S. Maria delle Croci Recruiting
Ravenna, Italy, 48121
Contact: Paolo Soliani, physician       paolo.soliani@auslromagna.it   
Principal Investigator: Paolo Soliani, physician         
Auo Chirurgia Generale Ospedale Degli Infermi Recruiting
Rimini, Italy, 47923
Contact: Gianluca Garulli, physician       gianluca.garulli@auslromagna.it   
Principal Investigator: Gianluca Garulli, physician         
Sponsors and Collaborators
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Investigators
Layout table for investigator information
Principal Investigator: Mattia Altini, physician IRST
Tracking Information
First Submitted Date May 28, 2019
First Posted Date June 11, 2019
Last Update Posted Date June 11, 2019
Actual Study Start Date April 16, 2019
Estimated Primary Completion Date December 31, 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: June 10, 2019)
  • health care resources utilization (HCRU) [ Time Frame: 90 day post surgery ]
    To identify the resources delivered to surgical patients. Resource are retrieved from administrative database.
  • Cost relate to HCRU [ Time Frame: 90 day post-surgery ]
    To identify the significant cost drivers for the surgical management of colorectal cancer patients and to verify the impact on economic resource consumption of the systematic auditing activities. Costs are retrieved from adminatrative database.
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures
 (submitted: June 10, 2019)
  • % of patients with post-operative complications [ Time Frame: 180 days post surgery ]
    To assess the frequency of post-operative complications, unplanned re-interventions and re-admission. This outcome is measured from data collected in Case Report Form (CRF)
  • Rate of mortality at 30 days [ Time Frame: 30 days post surgery ]
    To assess mortality rates at 30 days. This outcome is measured from data collected in CRF and from administrative database.
  • Rate of mortality at 90 days [ Time Frame: 90 days post surgery ]
    To assess mortality rates at 90 days. This outcome is measured from data collected in CRF and from administrative database.
  • Rate of mortality at 180 days [ Time Frame: 180 days post surgery ]
    To assess mortality rates at 180 days. This outcome is measured from data collected in CRF and from administrative database.
  • % of patients discussed in Multidisciplinary team meeting [ Time Frame: 180 days post surgery ]
    To assess the number of patient discussed within a multidisciplinary team meeting before colon rectal surgery. This outcome is measured from data collected in CRF.
  • % of patients who underwent minimally invasive resection [ Time Frame: 180 day post surgery ]
    To assess the number of minimally invasive resections. This outcome is measured from data collected in CRF.
  • Conversion rate [ Time Frame: 180 day post surgery ]
    to assess the rate of conversion surgery. This outcome is measured from data collected in CRF.
  • % of patients with adequacy of lymph node sampling [ Time Frame: 180 days post surgery ]
    To assess adequate intraoperative lymph node sampling of colorectal surgery. This outcome will be measured from data collected in CRF.
  • Rate of anastomosis [ Time Frame: 180 days post surgery ]
    To assess the rate of anastomosis after low anterior resection vs terminal colostomy. This outcome will be measured from relative data collected in CRF.
  • Rate of Miles procedure [ Time Frame: 180 days post surgery ]
    to assess the rate of Miles procedures in rectal cancer patients. This outcome is measured from data collected in CRF.
  • Quality of Total Mesorectal Excision: rate of positive Circumferential Resection Margin in patients with rectal cancer. [ Time Frame: 180 days post surgery ]
    To assess the rate of positive Circumferential Resection Margin in rectal cancer patient. This outcome will be measured from data collected in CRF.
  • Rate of loop ileostomy in patients with rectal cancer [ Time Frame: 180 days post surgery ]
    To assess the rate of loop ileostomy after rectal cancer resection. This outcome is measured from data collected in CRF.
  • % of patients with rectal cancer who underwent preoperative chemo-radiation therapy [ Time Frame: 180 days post surgery ]
    To assess the appropriateness of preoperative chemo-radiation therapy in rectal cancer patients. This outcome is measured from data collected in CRF.
  • Rate of preoperative chemo-radiation therapy in patients with rectal cancer [ Time Frame: 180 days post surgery ]
    To assess the rate of preoperative chemo-radiation therapy in rectal cancer patients. This outcome is measured from data collected in CRF.
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Emilia-Romagna Surgical Colorectal Cancer Audit- ESCA
Official Title A Plan for Evaluating Costs and Outcomes of Colorectal Surgery in Emilia-Romagna (Emilia-Romagna Surgical Colorectal Cancer Audit-ESCA)
Brief Summary Focus of this project is to evaluate the possible financial benefit resulting from an optimization of surgical outcomes throughout a collaborative and systematic auditing activity.The primary objective of this analysis is to assess the employed resources by National Health System related to surgical activities for primary colorectal cancer during a collaborative and systematic auditing activity in 8 Surgical Units of Emilia-Romagna
Detailed Description

Focus of this project is to evaluate the possible financial benefit resulting from an optimization of surgical outcomes throughout a collaborative and systematic auditing activity.

The primary objective of this analysis is to assess the employed resources by National Health System related to surgical activities for primary colorectal cancer during a collaborative and systematic auditing activity in 8 Surgical Units of Emilia-Romagna. A project team composed by experts in colorectal cancer care will be created with the task of identifying the needed resources to allocate to the project and the set of administrative, economic and performance indicators to be measured during the project. A friendly, time-preserving dataset that includes all the items to be collected to measure established indicators will be developed. An analysis on costs and performance indicators will be conducted on colorectal procedures performed between 1 January 2019 and 31 December 2019 within the participating centers. From the second year auditing activity will be implemented among institutions of Emilia-Romagna. Analysis results obtained from the first year of collecting data will be used as a starting feedback report to implement the auditing activity dedicated to colorectal cancer. During the whole second year monthly feedback reports will be drafted and used for monitoring costs and performances outcomes of colorectal surgery procedures between 1 January 2020 and 31 December 2020.

At the end of the second year a final analysis will be performed to compare resources employed for colorectal cancer surgery between the first and second year. Economical and performance data will be collected.

Focusing on costs, the main sources to be used are administrative databases. Full in-hospital costs will be collected for each patient for the time interval between the day of admission for surgery and the following post-operative 90-days. The Diagnosis Related Groups (DRG) standardized payments will be used to calculate inpatient costs.

Another source for cost and performance information is the clinical chart (paper or electronic) in all its parts. The investigators will focus primarily on set of data, that potentially could contribute to define the cost of care on basis of post-operative pathway. Key performance indicators common to both colon and rectal surgery or specific for one of the two surgical procedure will be considered.

Study Type Observational [Patient Registry]
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration 6 Months
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population All consecutive patients diagnosed with malignant colorectal cancer, who undergone at least one surgical procedure at one of participating hospitals during the observational period will be collected
Condition
  • Financial Benefit
  • Colorectal Cancer
  • Surgery
  • Auditing Activity
Intervention Procedure: all colorectal cancer surgical procedures
colorectal cancer surgical procedures
Study Groups/Cohorts
  • Colon surgery
    patients diagnosed with colon cancer, who undergone at least one surgical procedure at one of participating hospitals during the observational period
    Intervention: Procedure: all colorectal cancer surgical procedures
  • Rectal surgery
    patients diagnosed with rectal cancer, who undergone at least one surgical procedure at one of participating hospitals during the observational period
    Intervention: Procedure: all colorectal cancer surgical procedures
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: June 10, 2019)
1400
Original Estimated Enrollment Same as current
Estimated Study Completion Date December 31, 2020
Estimated Primary Completion Date December 31, 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Histological diagnosis of malignant colorectal cancer;
  • Underwent colorectal cancer surgery;

Exclusion Criteria:

• multiple synchronous primary tumours;

Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Italy
Removed Location Countries  
 
Administrative Information
NCT Number NCT03982641
Other Study ID Numbers IRST153.07
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: No
Responsible Party Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Study Sponsor Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Collaborators Not Provided
Investigators
Principal Investigator: Mattia Altini, physician IRST
PRS Account Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Verification Date June 2019

治疗医院